Pavmed Inc (PAVM) Stock Price, Quote & News

Company Profile

PAVmed Inc. engages in acquiring, developing, and commercializing novel products that target unmet needs in the United States. The company's lead products include CarpX, a patented, single-use, disposable, and minimally invasive surgical device for use in the treatment of carpal tunnel syndrome; EsoCheck Esophageal Cell Collection Device, which consists of diagnostic test that serves as a testing tool for preventing esophageal adenocarcinoma deaths, through early detection of esophageal precance...

Industry: Medical Devices

Sector: Healthcare

Phone: 917 813 1828

Website: www.pavmed.com

Address:

360 Madison Avenue, 25th Floor, New York, United States

tds_ Apr. 13 at 4:28 PM

$PAVM Scopia Holdings a 9.9% holder... Scopia Capital mgt is a $2 bil hedge fund according to various hedge fund websites. https://app.quotemedia.com/data/downloadFiling?webmasterId=101533&ref=319949218&type=HTML&symbol=PAVM&cdn=22956e8abc9cc2988ba64a06bc1ff588&companyName=PAVmed+Inc.&formType=SCHEDULE+13G&dateFiled=2026-04-13

1 · Reply

trout290zzaam Apr. 13 at 4:17 PM

$PAVM Another 13G

0 · Reply

DrKyle Apr. 13 at 4:06 PM

$LUCD $PAVM We all know what's coming....only the game is rigged for the elite to know when it is coming. It appears those people are now being placed on notice.

0 · Reply

ConditionalInvesting Apr. 13 at 3:46 PM

$LUCD Matthew Sirovich buying back into $PAVM signals something is def. afoot. He was a holder during the run-up to $9. I believe he sold all of his shares awhile ago. Don't take my word for gospel. Look into it yourself. https://app.quotemedia.com/data/downloadFiling?webmasterId=101533&ref=319949218&type=HTML&symbol=PAVM&cdn=22956e8abc9cc2988ba64a06bc1ff588&companyName=PAVmed+Inc.&formType=SCHEDULE+13G&dateFiled=2026-04-13

1 · Reply

Carter113 Apr. 10 at 6:13 PM

$LUCD $PAVM This was at NASDAQ yesterday incase anyone missed it!!!🔥

3 · Reply

tds_ Apr. 9 at 9:19 PM

$PAVM 4.4k shares traded today...lol. So old I remember when it traded 55 million shares in one session in January!

0 · Reply

BigJuicy Apr. 9 at 5:37 PM

$PAVM a little more pain before take off

1 · Reply

trout290zzaam Apr. 9 at 12:09 PM

$PAVM Couple of 13G from them, any of them mean anything?

1 · Reply

Tom__Brady Apr. 8 at 11:29 PM

$PAVM so 6.38 million common shares outstanding with today’s filing?

1 · Reply

Ironbow Apr. 6 at 12:57 PM

$LUCD $PAVM Dipsh!t, Dave / LPlates / dmc4321 must have accidentally blocked everyone. 🥇

0 · Reply

Lucid Diagnostics to Participate in Fireside Chat at the 25th Annual Needham Virtual Healthcare Conference

LUCD

Apr 2, 2026, 8:01 AM EDT - 11 days ago

PAVmed Appoints Joseph Virgilio to Lead Relaunched Medical Device Portfolio

LUCD

Mar 30, 2026, 8:00 AM EDT - 14 days ago

PAVmed Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results

LUCD

Mar 26, 2026, 8:00 AM EDT - 18 days ago

Lucid Diagnostics Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results

LUCD

Mar 16, 2026, 9:01 AM EDT - 4 weeks ago

PAVmed to Hold Fourth Quarter and Full Year 2025 Business Update Conference Call and Webcast on March 30, 2026

LUCD

Mar 12, 2026, 9:01 AM EDT - 4 weeks ago

Lucid Diagnostics to Hold Fourth Quarter and Full Year 2025 Business Update Conference Call and Webcast on March 26, 2026

LUCD

Feb 4, 2026, 8:01 AM EST - 2 months ago

PAVmed Closes Preferred Stock and Senior Secured Note Financings, Eliminating All Previously Outstanding Convertible Securities

LUCD

Jan 21, 2026, 3:40 PM EST - 2 months ago

Should you chase the rally in PAVmed stock after it quadrupled on Wednesday?

Jan 21, 2026, 8:00 AM EST - 2 months ago

Lucid Diagnostics Awarded U.S. Department of Veterans Affairs Contract for EsoGuard®

LUCD

Dec 30, 2025, 9:01 AM EST - 3 months ago

PAVmed Announces Reverse Stock Split

Dec 9, 2025, 8:01 AM EST - 4 months ago

Lucid Diagnostics Announces Positive Data from the Largest Reported Real-World Experience of Esophageal Precancer Detection

LUCD

Nov 20, 2025, 8:15 AM EST - 5 months ago

Lucid Diagnostics Named a GenomeWeb 2025 Best Places to Work Top-Ranking Honoree

LUCD

Nov 13, 2025, 8:15 AM EST - 5 months ago

Lucid Diagnostics to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum

LUCD

Nov 13, 2025, 8:00 AM EST - 5 months ago

PAVmed Provides Business Update and Reports Third Quarter 2025 Financial Results

LUCD

Nov 12, 2025, 8:00 AM EST - 5 months ago

Lucid Diagnostics Provides Business Update and Reports Third Quarter 2025 Financial Results

LUCD

Oct 30, 2025, 8:01 AM EDT - 5 months ago

PAVmed to Hold a Business Update Conference Call and Webcast on November 13, 2025

LUCD

Oct 29, 2025, 8:01 AM EDT - 5 months ago

Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on November 12, 2025

LUCD

Oct 15, 2025, 8:01 AM EDT - 6 months ago

Lucid Diagnostics to Participate in the 2025 Maxim Growth Summit

LUCD

Oct 7, 2025, 8:01 AM EDT - 6 months ago

PAVmed Subsidiary, Veris Health and The Ohio State University Comprehensive Cancer Center Launch Commercial Phase of Strategic Partnership Agreement

Sep 16, 2025, 8:01 AM EDT - 7 months ago

Lucid Diagnostics Appoints Danielle Scelfo as Senior Vice President, Market Access & Government Affairs

LUCD

Sep 11, 2025, 9:17 AM EDT - 7 months ago

Lucid Diagnostics Announces Closing of Public Offering of Common Stock

LUCD

Sep 10, 2025, 8:00 AM EDT - 7 months ago

Lucid Diagnostics Announces Pricing of Public Offering of Common Stock

LUCD

Sep 9, 2025, 4:01 PM EDT - 7 months ago

Lucid Diagnostics Announces Proposed Public Offering of Common Stock

LUCD

Sep 5, 2025, 9:16 AM EDT - 7 months ago

Lucid Diagnostics to Host Investor Call on Monday, September 8, 2025

LUCD

Aug 27, 2025, 8:00 AM EDT - 8 months ago

Lucid Diagnostics to Participate in the Cantor Global Healthcare Conference 2025

LUCD

Aug 26, 2025, 8:01 AM EDT - 8 months ago

PAVmed Signs Letter of Intent to License Groundbreaking Endoscopic Esophageal Imaging Technology

LUCD

Aug 14, 2025, 8:00 AM EDT - 8 months ago

PAVmed Provides Business Update and Reports Second Quarter 2025 Financial Results

LUCD

Aug 13, 2025, 8:00 AM EDT - 8 months ago

Lucid Diagnostics Provides Business Update and Reports Second Quarter 2025 Financial Results

LUCD

Aug 5, 2025, 8:00 AM EDT - 8 months ago

Lucid Diagnostics to Participate in Upcoming Investor Conferences

LUCD

Jul 31, 2025, 8:01 AM EDT - 9 months ago

PAVmed to Hold a Business Update Conference Call and Webcast on August 14, 2025

LUCD

Jul 30, 2025, 8:01 AM EDT - 9 months ago

Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on August 13, 2025

LUCD

Jul 30, 2025, 8:00 AM EDT - 9 months ago

PAVmed Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Rule

LUCD

Jul 16, 2025, 7:31 AM EDT - 9 months ago

MolDX to Convene Expert Medical Panel on Medicare Local Coverage Determination (LCD) for Lucid Diagnostics' EsoGuard® Esophageal DNA Test

LUCD

Jun 24, 2025, 8:01 AM EDT - 10 months ago

PAVmed Subsidiary Veris Health Completes $2.5 Million Direct Equity Financing

Jun 18, 2025, 12:02 PM EDT - 10 months ago

Major California Health System Launches Comprehensive Esophageal Precancer Testing Program Using Lucid Diagnostics' EsoGuard® Esophageal DNA Test

LUCD

Jun 3, 2025, 8:31 AM EDT - 11 months ago

PAVmed Subsidiary, Veris Health, Enters into Strategic Partnership Agreement with The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute

May 27, 2025, 7:31 AM EDT - 11 months ago

Lucid Diagnostics to Join Russell 2000® and Russell 3000® Indexes

LUCD

May 15, 2025, 8:01 AM EDT - 11 months ago

PAVmed Provides Business Update and Reports First Quarter 2025 Financial Results

LUCD

May 14, 2025, 8:01 AM EDT - 11 months ago

Lucid Diagnostics Provides Business Update and Reports First Quarter 2025 Financial Results

LUCD

May 1, 2025, 8:31 AM EDT - 1 year ago

PAVmed to Hold a Business Update Conference Call and Webcast on May 15, 2025

LUCD

Apr 30, 2025, 8:31 AM EDT - 1 year ago

Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on May 14, 2025

LUCD

Apr 24, 2025, 8:01 AM EDT - 1 year ago

NCI-Sponsored Study Shows Positive Data for Lucid Diagnostics' EsoGuard® Esophageal DNA Test in Patients Without Symptomatic GERD

LUCD

Apr 3, 2025, 9:00 AM EDT - 1 year ago

Lucid Diagnostics to Participate in Fireside Chat at the 24th Annual Needham Virtual Healthcare Conference

LUCD

Mar 27, 2025, 8:01 AM EDT - 1 year ago

Lucid Diagnostics Launches "Embrace the Future" Campaign Showcasing EsoCheck's Groundbreaking Collect+Protect Esophageal Cell Collection Technology

LUCD

Mar 25, 2025, 8:01 AM EDT - 1 year ago

PAVmed Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results

Mar 24, 2025, 8:01 AM EDT - 1 year ago

Lucid Diagnostics Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results

LUCD

Mar 20, 2025, 8:31 AM EDT - 1 year ago

Lucid Diagnostics Announces Updated National Comprehensive Cancer Network® (NCCN) Guidelines Now Include Esophageal Precancer Screening

LUCD

Mar 18, 2025, 8:31 AM EDT - 1 year ago

Lucid Diagnostics' ENVET-BE Clinical Utility Study of EsoGuard® Esophageal Precancer Testing Accepted for Peer-Reviewed Publication

LUCD

Mar 13, 2025, 7:36 AM EDT - 1 year ago

Lucid Diagnostics Secures First Positive Commercial Insurance Coverage Policy for its EsoGuard® Esophageal DNA Test

LUCD

Mar 10, 2025, 9:01 AM EDT - 1 year ago

Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on March 24, 2025

LUCD

tds_ Apr. 13 at 4:28 PM

1 · Reply

trout290zzaam Apr. 13 at 4:17 PM

$PAVM Another 13G

0 · Reply

DrKyle Apr. 13 at 4:06 PM

$LUCD $PAVM We all know what's coming....only the game is rigged for the elite to know when it is coming. It appears those people are now being placed on notice.

0 · Reply

ConditionalInvesting Apr. 13 at 3:46 PM

1 · Reply

Carter113 Apr. 10 at 6:13 PM

$LUCD $PAVM This was at NASDAQ yesterday incase anyone missed it!!!🔥

3 · Reply

tds_ Apr. 9 at 9:19 PM

$PAVM 4.4k shares traded today...lol. So old I remember when it traded 55 million shares in one session in January!

0 · Reply

BigJuicy Apr. 9 at 5:37 PM

$PAVM a little more pain before take off

1 · Reply

trout290zzaam Apr. 9 at 12:09 PM

$PAVM Couple of 13G from them, any of them mean anything?

1 · Reply

Tom__Brady Apr. 8 at 11:29 PM

$PAVM so 6.38 million common shares outstanding with today’s filing?

1 · Reply

Ironbow Apr. 6 at 12:57 PM

$LUCD $PAVM Dipsh!t, Dave / LPlates / dmc4321 must have accidentally blocked everyone. 🥇

0 · Reply

oaksapollo Apr. 3 at 11:36 PM

$LUCD $PAVM this is interesting. Do you think this is "the" Craig Kallman? 6% ownership https://app.quotemedia.com/data/downloadFiling?webmasterId=101533&ref=319935188&type=HTML&symbol=PAVM&cdn=83aecc5aac0b7c201d45c7e3106324d5&companyName=PAVmed+Inc.&formType=SCHEDULE+13G&dateFiled=2026-04-03 https://en.wikipedia.org/wiki/Craig_Kallman

1 · Reply

chuckjackson Apr. 2 at 6:26 PM

$PAVM the S-8 is not as troubling as an imminent S-1/S-3 filing for the sale of 4.61M shares

1 · Reply

Tom__Brady Apr. 2 at 12:21 PM

$PAVM lol another 1,555,340 shares "newly reserved for issuance" this morning with the announcement of our new Medical Device Portfolio leader....

2 · Reply

tds_ Apr. 2 at 12:06 PM

$PAVM As they mentioned on the recent earnings call. PAVmed Appoints Joseph Virgilio to Lead Relaunched Medical Device Portfolio - PAVmed is actively pursuing additional medical device opportunities across various subsectors, with a focus on those with synergies to existing assets, including promising gastroesophageal reflux-focused technologies. https://ir.pavmed.com/2026-04-02-PAVmed-Appoints-Joseph-Virgilio-to-Lead-Relaunched-Medical-Device-Portfolio

0 · Reply

BigJuicy Mar. 31 at 11:45 AM

$LUCD $PAVM any day could release the LCD draft. It’s seeming more and more likely this will occur sometime in June 2026 which is only 2 months away! Be brave and hold or accumulate on weakness. I am guessing 2$+ on LCD approval. Then inching up to 5$ once they can prove profitability in the next 18-24 months following approval. There is also the possibility of a buyout nearing 10$+. They should be able to hold out without a raise but I wouldn’t be surprised to see one on or near the LCD approvals to fund continuing operations. I’m down on my position and will buy more if LUCD decides to go below $1 or PAVM goes below 6.50

0 · Reply

MikiTrader Mar. 31 at 6:46 AM

$PAVM If it’s going to move, I think there are still more than two months left. And what’s with the guys grinning after pushing it up 13% with just 38k shares?

1 · Reply

Thegame7000 Mar. 30 at 8:24 PM

$PAVM bouncin’…for you OG’s in here

0 · Reply

Thegame7000 Mar. 30 at 8:23 PM

$PAVM even Creed approves of that close…and says, “Can you take me higher”…

0 · Reply

Investor_Scale Mar. 30 at 8:17 PM

$PAVM nice close!

0 · Reply

Investor_Scale Mar. 30 at 5:32 PM

$PAVM https://finance.yahoo.com/markets/stocks/articles/pavmed-pavm-upgraded-buy-heres-160003658.html

0 · Reply

pueblo2006 Mar. 30 at 12:53 PM

$PAVM

0 · Reply

trout290zzaam Mar. 30 at 12:52 PM

$PAVM $LUCD https://ir.pavmed.com/2026-03-30-PAVmed-Provides-Business-Update-and-Reports-Fourth-Quarter-and-Full-Year-2025-Financial-Results

0 · Reply

Market Cap	9.20M
Revenue (ttm)	70,000.00
Net Income (ttm)	400,000.00
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	571.43%
Debt to Equity Ratio	0.00

Volume	8,300
Avg Vol	83,280
Day's Range	N/A - N/A
Shares Out	996,000.00
Stochastic %K	19%
Beta	0.81
Analysts	Sell
Price Target	$16.00